Activist bids rise as markets scrutinize buyers and targets unequally
Activist bids are increasing, with 14 US campaigns this year, up from last year. Advisers note that bids force boards to consider offers seriously but warn against empty tactics. Examples include Ancora's potential bid for HB Fuller (FUL) and Fund 1 Investments' take-private offer for Xponential Fitness (XPOF). Live prices show mixed reactions to recent bids, with some buyers facing scrutiny.
How this was made
The 30-second read
Why it matters
It suggests markets are discounting bidder credibility and financing, while targets can benefit when investors expect better offers or deal concessions.
Market read
Traders can use the buyer-versus-target repricing message to manage risk around activist and takeover headlines, but the article provides no new deal terms beyond live price snapshots and qualitative expectations.
What to watch
The article admits it cannot confirm what drove each move; without deal-specific catalysts (financing updates, revised terms, regulatory signals), trading signals may be noisy.
Background
The piece frames activist bids as mainstream and compares live market reactions across several US and European situations, emphasizing unequal pricing of buyers versus targets.
Ticker impact
Telus is the target of Quebecor’s bid, and TU trades down with “no bid premium visible today,” signaling limited immediate deal support.
Choppy to slightly negative as traders wait for evidence of a higher offer or premium.
The article explicitly notes TU’s decline and absence of visible premium, which typically caps upside until terms improve.
HB Fuller is an activist target where Ancora keeps the option of bidding for all after two rejected bids for its building unit.
Range-bound to slightly positive as investors weigh activist optionality against lack of deal premium.
The article notes FUL moves with the market and shows no obvious deal premium today, reducing conviction.
Xponential Fitness is an activist target where Fund 1 Investments seeks a take-private, but the article says there is little take-private premium today.
Neutral to slightly negative as the market discounts the bid’s premium for now.
The piece explicitly highlights “little take-private premium” and only a small positive move, implying weak immediate repricing.
Market effects
Reinforces that M&A and activist outcomes are increasingly sensitive to financing costs and stakeholder politics, not just headline offer size.
US equities are weak and volatility elevated, which can pressure bidder stock performance during takeover scrutiny.
European takeover dynamics (works councils, labor support) are highlighted as a cross-border constraint on deal certainty and pricing.
Counterpoint
Price weakness in bidders may reflect broader market risk rather than deal-specific failure, so targets could still re-rate if financing and terms improve quickly.
Key entities
- bidderQuebecor Inc
Named bidder for Telus, with its approach tied to a sharp decline in its class B shares in the article’s live table.
- targetTelus Corp
Named target of Quebecor’s approach, with the article noting no visible bid premium and a down day for TU.
- bidderBASF SE
Named bidder for Evonik, with the article highlighting priced-in concessions and watching a revised offer.
- targetEvonik Industries AG
Named target of BASF, with the article noting EVKn is up and markets expect a better offer.
- activist targetHB Fuller Company
Ancora keeps the option of bidding for all after rejected bids for a building unit; article notes no obvious premium today.


